MoodMark®’s scientific discoveries offer the potential to change the clinical management of depression and the productivity of new therapy research and development landscapes through six product applications:
Clinical Applications
MoodMark® Dx
Helps diagnose presence and severity of depression within days
MoodMark® Rx
Tests antidepressant effectiveness within days
MoodMark® Px
Personalizes antidepressant prescriptions within days
Pharma Applications
MoodMark® LS
Screens company drug libraries for antidepressant potential
MoodMark® PS
Confirms clinical trial subjects' depressed state
MoodMark® TE
Quantitatively measures
subjects' endpoint dispositions
Clinical Application Pipeline
MoodMark® has the potential to change the depression landscape with quantitative and rapid biological diagnosis and treatment effectiveness tests.
Application
MoodMark® Dx
Purpose
Aid diagnosis
Frequency
Upon intake
Upon diagnosis
Semi-annual follow-ups
Turnaround
Within days
Anticipated Launch
Q2:27
Application
MoodMark® Rx
Purpose
Measure treatment efficacy
Frequency
One week after prescription started
Semi-annual medication effectiveness test
Turnaround
Within days
Anticipated Launch
Q4:27
Application
MoodMark® Px
Purpose
Personalize treatment choice based on blood samples run against ~100 medication alternatives
Frequency
After diagnosis, before prescription
Semi-annual medication effectiveness test
Turnaround
Within days
Anticipated Launch
2028
Pharma Application Pipeline
MoodMark® helps reveal potential depression pathway target activity in pharmaceutical companies’ existing drug libraries, and helps strengthen clinical drug trial subject selection and trial drug response results.
Application
MoodMark® LS
Purpose
Test drugs within pharma company portfolios to identify antidepressant
Frequency
Broad initial testing for any drugs suspected of having antidepressant applications
Turnaround
Within days
Anticipated Launch
Q4:25
Application
MoodMark® PS
Purpose
Ensure that subjects in depression-related clinical trials pass objective depression measurement
Frequency
Screen each prospective subject before clinical trials
Turnaround
Within days
Anticipated Launch
Q4:27
Application
MoodMark® Px
Purpose
Test clinical trial subjects at trial measurement points to evaluate drug impact
Frequency
Test at frequency of trial protocol
Turnaround
Within days
Anticipated Launch
Q4:27